Dexcom Ventures, the venture capital arm of Dexcom, focuses its investments on emerging continuous glucose monitoring (CGM) technologies, devices that measure other substances, sensing technology, data analytics, remote patient monitoring, and population health. Its strategy is to be a value-add strategic investor, leveraging Dexcom's industry expertise to support early-stage companies pioneering new markets.
100% of their portfolio is in Healthcare. Their most common stage is series-d (40% of deals). Average disclosed round size is $64.4M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series D
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
Top Co-Investors
GV (Google Ventures)2 shared
Fidelity Investments1 shared
Cheyenne Ventures1 shared
Samsung Ventures1 shared
Artesian1 shared
Last updated: 8 March 2026